Sonophoretic enhanced transdermal transport

• US 6,190,315 B1
• Filed: 01/08/1999
• Issued: 02/20/2001
• Est. Priority Date: 01/08/1998
• Status: Expired due to Fees

• Current Assignee: Echo Therapeutics Incorporated
• Original Assignee: Sontra Medical, Inc. (Echo Therapeutics Incorporated)
• Inventors: Langer, Robert S., Mitragotri, Samir S., Kost, Joseph
• Primary Examiner(s): Winakur, Eric F.
• Assistant Examiner(s): CADUGAN, JOSEPH A
• Application Number:
  US09/227,623
• Time in Patent Office: 774 Days
• Field of Search: 604/20, 604/22, 604/49, 600/578, 600/573, 600/309, 601/2
• US Class Current: 600/309
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61M 2037/0007 having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis

Abstract

Methods for enhanced transdermal transport wherein the application of ultrasound is required only once for repeated or sustained transdermal extraction or delivery, over a period of time, rather than prior to each extraction or delivery. The method is applicable to analyte extraction, as well as for drug delivery. The method involves the initial application of an amount of low frequency ultrasound effective to permeabilize the skin or membrane followed by analyte extraction or drug delivery over a period of time. The initial application of ultrasound is effective to permeabilize the skin or membrane for at least about 30 minutes, preferably at least one to two hours, and more preferably up to four to ten hours. The ultrasound is preferably low frequency ultrasound, less than 2.5 MHz, more preferably less than 1 MHz. The transdermal transport can be enhanced by the application of a secondary driving force such as suction, osmotic pressure gradient, concentration gradient, iontophoresis, electroporation, magnetic field, additional ultrasound, or mechanical pressure.

Claims

1. A method for enhanced transport of a molecule into or through skin, comprising the steps:

permeabilizing the skin by applying low frequency ultrasound to the area of the skin where permeabilization is desired, wherein the frequency of the ultrasound is between about 20 kHz and 1 MHz;

subsequently applying a driving force to extract analyte molecules through or to deliver drug molecules into the skin over a period of time following the permeabilization without repermeabilizing the skin.

2. The method of claim 1 further comprising repeating the permeabilizing step between 1 and 10 hours later.

3. The method of claim 1, further comprising applying a chemical enhancer.

4. The method of claim 1 wherein the driving force is selected from the group consisting of suction, osmotic pressure gradient, concentration gradient, capillary forces, convection, iontophoresis, electroporation, magnetic fields, and mechanical pressure.

5. The method of claim 1, further comprising the step of applying a cavitation enhancer to the skin or in a coupling medium.

6. The method of claim 1, wherein the step of permeabilizing the skin is effective to permeabilize the skin for at least 30 minutes.

7. The method of claim 1 further comprising applying surfactant to the skin or in a coupling medium at the time of permeabilization.

8. The method of claim 1, further comprising analyzing the analyte concentration at the time of extraction or the concentration of the drug or marker to be transported.

9. The method of claim 1, further comprising providing a reservoir into which analyte molecules are extracted.

10. The method of claim 1, further comprising providing a reservoir for delivery of the drug molecules.

11. The method of claim 1 further comprising providing a transdermal patch for delivery of molecules to be transported or collection of analyte to be extracted.

12. The method of claim 1, further comprising the step of determining the degree of permeabilization.

13. The method of claim 1 further comprising measuring the concentration of a molecule present in interstitial fluid that remains relatively constant, for use in determining the degree of permeabilization or calibrating the concentration of molecules to be transported.